Challenges and lessons learned from COVID-19 trials: should we be doing clinical trials differently?

P Janiaud, LG Hemkens, JPA Ioannidis - Canadian Journal of Cardiology, 2021 - Elsevier
The COVID-19 crisis led to a flurry of clinical trials activity. The COVID-evidence database
shows 2814 COVID-19 randomized trials registered as of February 16, 2021. Most were …

Venovenous extracorporeal membrane oxygenation in patients with acute covid-19 associated respiratory failure: comparative effectiveness study

M Urner, AG Barnett, GL Bassi, D Brodie, HJ Dalton… - bmj, 2022 - bmj.com
Objective To estimate the effect of extracorporeal membrane oxygenation (ECMO)
compared with conventional mechanical ventilation on outcomes of patients with covid-19 …

Challenges and solutions in clinical research during the COVID‐19 pandemic: A narrative review

M Nomali, N Mehrdad, ME Heidari, A Ayati… - Health science …, 2023 - Wiley Online Library
Abstract Background and Aims The COVID‐19 pandemic has presented significant
challenges to clinical research, necessitating the adoption of innovative and remote …

Results reporting for clinical trials led by medical universities and university hospitals in the Nordic countries was often missing or delayed

G Nilsonne, S Wieschowski, NJ DeVito… - MedRxiv, 2024 - medrxiv.org
Objective: To systematically evaluate timely reporting of clinical trial results at medical
universities and university hospitals in the Nordic countries. Study Design and Setting: In this …

Dissemination of Registered COVID-19 Clinical Trials (DIRECCT): a cross-sectional study

M Salholz-Hillel, M Pugh-Jones, N Hildebrand… - BMC medicine, 2023 - Springer
Background The results of clinical trials should be completely and rapidly reported during
public health emergencies such as COVID-19. This study aimed to examine when, and …

How informative were early SARS-CoV-2 treatment and prevention trials? A longitudinal cohort analysis of trials registered on ClinicalTrials. gov

N Hutchinson, K Klas, BG Carlisle, J Kimmelman… - Plos one, 2022 - journals.plos.org
Background Early in the SARS-CoV-2 pandemic, commentators warned that some COVID
trials were inadequately conceived, designed and reported. Here, we retrospectively assess …

Results availability and timeliness of registered COVID-19 clinical trials: interim cross-sectional results from the DIRECCT study

M Salholz-Hillel, P Grabitz, M Pugh-Jones, D Strech… - BMJ open, 2021 - bmjopen.bmj.com
Objective To examine how and when the results of COVID-19 clinical trials are
disseminated. Design Cross-sectional study. Setting The COVID-19 clinical trial landscape …

Factors that impact on recruitment to vaccine trials in the context of a pandemic or epidemic: a qualitative evidence synthesis

P Meskell, LM Biesty, M Dowling… - Cochrane Database …, 2023 - cochranelibrary.com
Background The World Health Organization declared the COVID‐19 pandemic on 11 March
2020. Vaccine development and deployment were swiftly prioritised as a method to manage …

Target and actual sample sizes for studies from two trial registries from 1999 to 2020: an observational study

AG Barnett, P Glasziou - BMJ Open, 2021 - bmjopen.bmj.com
Objectives To investigate differences between target and actual sample sizes, and what
study characteristics were associated with sample sizes. Design Observational study …

Hydroxychloroquine to prevent SARS-Cov-2 infection among Healthcare workers: early termination of a phase 3, randomised, open-label, controlled clinical trial

A Llanos-Cuentas, A Schwalb, JL Quintana, B Delfin… - BMC research …, 2023 - Springer
Objective To assess the effectiveness and safety of hydroxychloroquine (HCQ) prophylaxis
for the prevention of SARS-CoV-2 infection in healthcare workers (HCW) on duty during the …